2023 was a big year in the world of diabetes, from the FDA’s approval of a new bionic pancreas to promising cell therapy trial results, and lots of stuff in between. It’s easy to forget how far we’ve come in such a short period of time, so here’s a recap of several key advancements that were made this year.

There’s a new kid on the block in the diabetes management space – embecta. Formerly part of BD, who introduced the world’s first specialized insulin syringe in 1924, embecta plans to empower people with diabetes to live their best life through educational initiatives, product refreshes, and new product developments.